Prime Medicine Q3 EPS $(0.22) Beats $(0.25) Estimate, Sales $4.213M Beat $1.206M Estimate
Benzinga Newsdesk 10 hours ago
NewsEarningsEarnings Beats
Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent. This is a 31.25 percent increase over losses of $(0.32) per share from the
Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent. This is a 31.25 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $4.213 million which beat the analyst consensus estimate of $1.206 million by 249.34 percent. This is a 243.92 percent increase over sales of $1.225 million the same period last year.